Status:
RECRUITING
Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers
Lead Sponsor:
GCS Ramsay Santé pour l'Enseignement et la Recherche
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Squamous cell cancers of the head and neck are classically correlated to excessive consumption of alcohol and tobacco and have a rather poor prognosis. However, the incidence of Head and Neck cancers ...
Detailed Description
Head and neck cancers are the sixth most common cancer common worldwide causing more than 380,000 deaths each year. More than 90% of these cancers are carcinomas epidermoids arising from the mucosal s...
Eligibility Criteria
Inclusion
- Patient with oropharyngeal squamous cell carcinoma or the oral cavity histologically proven.
- Primary tumor for which a biopsy or excision is required available and sufficient to carry out molecular analysis
Exclusion
- \- Patient with Head and Neck cancer other than oropharyngeal or oral cavity squamous cells carcinomas
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06133790
Start Date
January 1 2024
End Date
June 30 2024
Last Update
February 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Privé Clairval
Marseille, France, 13009